Home/Filings/4/0001209191-20-011559
4//SEC Filing

Ajmani Karin 4

Accession 0001209191-20-011559

CIK 0001551306other

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 4:38 PM ET

Size

11.4 KB

Accession

0001209191-20-011559

Insider Transaction Report

Form 4
Period: 2020-02-19
Ajmani Karin
EVP, Chief of Strategic Dev.
Transactions
  • Exercise/Conversion

    Common Stock

    2020-02-19$0.87/sh+447,472$389,3011,085,513 total
  • Exercise/Conversion

    Common Stock

    2020-02-19$0.91/sh+43,047$39,1731,128,560 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2020-02-19447,472174,914 total
    Exercise: $0.87Exp: 2025-09-15Common Stock (447,472 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2020-02-1943,047344,377 total
    Exercise: $0.91Exp: 2027-08-03Common Stock (43,047 underlying)
Footnotes (3)
  • [F1]This amount eliminates two shares which, as a result of a mathematical error, were first inadvertently included in the amount of securities beneficially owned beginning with the Reporting Person's Form 4 filed October 24, 2019.
  • [F2]Fully Vested.
  • [F3]One-fourth (1/4th) of the shares subject to the Option vested on April 1, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Issuer

Progyny, Inc.

CIK 0001551306

Entity typeother

Related Parties

1
  • filerCIK 0001789516

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:38 PM ET
Size
11.4 KB